Report of the ASEAN-Japan Risk Management Plan Seminar 2023

The ASEAN–Japan Risk Management Plan Seminar 2023 was held on May 25 and 26, in Jakarta, Indonesia, and was co-hosted by the Indonesian Food and Drug Authority (Indonesian FDA), the PMDA, and the University of Indonesia. The target audience of the seminar comprised the regulators of the ASEAN Member States (AMS). Thirty-nine participants attended the seminar. This seminar was also supported by the JAIF as was the ASEAN–Japan Risk Management Plan Symposium 2023. At the seminar, a PMDA staff from the Office of Pharmacovigilance I delivered a lecture on how to evaluate the Risk Management Plan (RMP), and a representative of the Japan Pharmaceutical Manufacturers Association (JPMA) provided group work guidance. After these lectures, group work on RMP development was conducted. The participants actively exchanged opinions and deepened their understanding of pharmaceutical risk management. At the end of the seminar, Dr. UZU, Senior Executive Director of the PMDA, awarded a certificate of participation to the participants. The details of the seminar are available at the following link :
https://aseanrmp.ui.ac.id